Name of Gene | Annotation (essential genes) | Gene GC% (M. tb= 65%) | Presence of HGT vehicle (Yes or No) |
---|---|---|---|
List A | |||
Rv0082 to Rv0087 | hyc locus (82 ex vivo; 85–86 in vitro) | 69.1 | N |
Rv0113 to Rv0115 | sedoheptulose-7-phosphate isomerase | 61.3 | N |
Rv1006 | Glycosyl transferase | 65 | N |
Rv1513/14c, Rv1516c, Rv1518 and Rv1520 | LOS locus (14c: in vivo) | NA | Y |
Rv1722 | Carboxylase | 67 | Y |
Rv2067c | Methyltransferase | 59.5 | Y |
Rv2387 | Permease (in vivo) | 61.8 | N |
Rv2531 | Arginine Decarboxylase | 63.4 | Y |
Rv2561/62 | H.P | 59.9 | N |
Rv2633c | Hemerythrin HHE cation binding domain scavenger | 60.8 | N |
Rv2955c to Rv2957 and Rv2963 | PGL locus | NA | Y |
Rv3528c | Methyltransferase | 48.6 | N |
Rv3768 | Permease | 61.8 | Y |
Rv3788 | Transcription Elongation GreA | 66.3 | N |
List B | |||
Rv0104 | cAMP-kinase regulatory subunit | 63.8 | N |
Rv0193c | H.P. | 61.6 | N |
Rv0213c/14c | Methyltransferase and NadR | 63.4 | N |
Rv0347 | H.P (in vitro) | 62.1 | N |
Rv0379 | SecE2 | 63.4 | N |
Rv0520/21 | Methyltransferase | 62.1 | N |
Rv0793 | Antibiotique monooxygenase | 66.3 | Y |
Rv0899 | OmpA | 60.8 | N |
Rv1192 | PGAP1 family (in vivo) | 67.8 | N |
Rv1289 | H.P | 60.0 | N |
Rv1371 to Rv1376 | Fatty acid desaturase, Pks18, glycolipid sulfotransferase, TfuA like protein (71: in vivo) | 63.4 | Y |
Rv1500 to Rv1508c and Rv1525 | LOS locus | NA | Y |
Rv1541c | H.P. | 63.5 | N |
Rv1732 | Thioredoxin | 69.6 | N |
Rv1749 | H.P. | 62.2 | N |
Rv1995 | Hemerythrin HHE cation binding domain scavenger | 63 | Y |
Rv2075c | C-type lectin domain | 68.3 | N |
Rv2277 | Glycerophosphodiesterase (GdpD) (in vivo) | 61.9 | Y |
Rv2289 | CDP-diacylgylcerol pyrophosphatase | 57.5 | N |
Rv2636 | chloramphenicol 3-O-phosphotransferase | 63.4 | N |
Rv2761c | type I restriction/modification system | 63.7 | Y |
Rv2949c | PGL locus: 4-hydroxybenzoate synthetase | 52.5 | Y |
Rv2958c and Rv2962c | PGL locus: glycosyltransferase | 64.8 and 65.8 | Y |
Rv3091 | patatin-like phospholipase family protein | 69.4 | N |
Rv3172c | H.P. | 59.6 | N |
List C | |||
Rv0325/26 | Methyltransferase (26: in vivo) | 63.9 | N |
Rv0611c | H.P. | 63.9 | Y |
Rv0628c and Rv0874c | H.P. (28c: in vitro) | 72.2 and 70.5 | Y and N |
Rv1498c | Los locus: Methyltransferase | 58.7 | Y |
Rv1671 | H.P. | 62.1 | N |
Rv2292c/93c | Methylthioadenosine nucleosidase | 63.9 | N |
Rv2959c | PGL Locus: Methyltransferase | 53.7 | Y |
Rv3081 | H.P. | 64.8 | N |
Rv3138 | Pyruvate formate lyase activating enzyme | 61.9 | N |
Rv3373/74/75 | Enoyl-CoA Hydratase 18, Amidase (75: in vivo) | 59.7 | Y |
List D | |||
Rv0032/33 | BioF/AcpA | 61.6 | Y |
Rv0059/60 | Appr1-P (60: in vitro) | 60.8 | Y |
Rv0078A | H.P. | 61.1 | N |
Rv0329c/30c | Methyltransferase, TetR | 67.5 | N |
Rv0987/88 | Adhesion/permease and hydroxymethylcoA reducatase | 53.9 | N |
Rv1045 to Rv1049 | H.P. (45 and 49: ex vivo) | 64.6 | Y |
Rv1509 and Rv1515c | LOS locus: Methyltransferase | NA | Y |
Rv1552 to Rv1555 | Fumarate reductase | 63.4 | Y |
Rv1673c/74c | transglutaminase-like/ArsR | 64 | N |
Rv2003c, Rv2008c and Rv2011c | Methyltransferase/ATPase, AAA+/H.P. GI4 | NA | Y |
Rv2295 | H.P. | 64.5 | N |
Rv2336/37c/38c | Molybdoterine thyamine synthesis (38c: in vitro) | 58.8 | N |
Rv2432c/33c | H.P. | 63.8 | N |
Rv2491/92 | H.P. | 54.8 | Y |
Rv2735 | H.P. | 56.5 | Y |
Rv2804c and Rv2816c to Rv2826c | H.P. GI6 (17c: in vitro) | 62.1 | Y |
Rv2954c | PGL locus: Methyltransferase | 62.8 | Y |
Rv2990c | Methyltransferase | 62.5 | N |
Rv3122/23 | H.P. | 67.8 | N |
Rv3189/90c | filamentous haemagglutinin-adhesin/H.P. | 62.0 | Y |
Rv3376/77c/78c | Production of the halimane skeleton (76c: ex vivo) | 54.7 | Y |
Rv3402c/03c/04c | Aminotransferase/FAD dependent oxidoreductase/formyltransferase | 62.6 | Y |
Rv3471 | Cupin family protein | 65.9 | Y |